195 related articles for article (PubMed ID: 23027683)
1. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.
Marasca R; Maffei R; Martinelli S; Fiorcari S; Bulgarelli J; Debbia G; Rossi D; Rossi FM; Rigolin GM; Martinelli S; Gattei V; Del Poeta G; Laurenti L; Forconi F; Montillo M; Gaidano G; Luppi M
Hematol Oncol; 2013 Jun; 31(2):88-95. PubMed ID: 23027683
[TBL] [Abstract][Full Text] [Related]
2. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
3. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
5. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.
Döhner H; Stilgenbauer S; James MR; Benner A; Weilguni T; Bentz M; Fischer K; Hunstein W; Lichter P
Blood; 1997 Apr; 89(7):2516-22. PubMed ID: 9116297
[TBL] [Abstract][Full Text] [Related]
6. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
Van Dyke DL; Werner L; Rassenti LZ; Neuberg D; Ghia E; Heerema NA; Dal Cin P; Dell Aquila M; Sreekantaiah C; Greaves AW; Kipps TJ; Kay NE
Br J Haematol; 2016 Apr; 173(1):105-13. PubMed ID: 26848054
[TBL] [Abstract][Full Text] [Related]
7. A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Sanzo C; Aventín A; Puiggros A; Collado R; Heras C; Muñoz C; Delgado J; Ortega M; González MT; Marugán I; de la Fuente I; Recio I; Bosch F; Espinet B; González M; Hernández-Rivas JM; Hernández JÁ; ;
Hematol Oncol; 2016 Jun; 34(2):84-92. PubMed ID: 25689772
[TBL] [Abstract][Full Text] [Related]
8. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
11. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
Delgado J; Espinet B; Oliveira AC; Abrisqueta P; de la Serna J; Collado R; Loscertales J; Lopez M; Hernandez-Rivas JA; Ferra C; Ramirez A; Roncero JM; Lopez C; Aventin A; Puiggros A; Abella E; Carbonell F; Costa D; Carrio A; Gonzalez M; ;
Br J Haematol; 2012 Apr; 157(1):67-74. PubMed ID: 22224845
[TBL] [Abstract][Full Text] [Related]
12. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
13. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
14. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice.
Doubek M; Mayer J; Obrtlíková P; Smolej L; Cmunt E; Schwarz J; Brejcha M; Kozmon P; Pospíšilová S; Brychtová Y; Pospíšil Z; Trněný M
Eur J Haematol; 2011 Aug; 87(2):130-7. PubMed ID: 21535162
[TBL] [Abstract][Full Text] [Related]
15. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Zenz T; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
[TBL] [Abstract][Full Text] [Related]
16. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
17. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
[TBL] [Abstract][Full Text] [Related]
19. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
[TBL] [Abstract][Full Text] [Related]
20. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
